Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
      Biotech

      Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

      January 9, 2026
      Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD
      Biotech

      Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD

      January 8, 2026
      AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board
      Biotech

      AstronauTx appoints experienced biotech executive Adam Rosenberg as Chair of the Board

      January 7, 2026
      CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million
      Biotech

      CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million

      January 6, 2026
      GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
      Biotech

      GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

      January 5, 2026
      Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
      Biotech

      Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference

      January 4, 2026
      MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations
      Biotech

      MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations

      January 3, 2026
      Last day of trading in shares with pre-emptive rights in connection with rights issue
      Biotech

      Last day of trading in shares with pre-emptive rights in connection with rights issue

      January 2, 2026
      The End of Shots? 5 Biotech Stocks Rethinking Diabetes
      Biotech

      The End of Shots? 5 Biotech Stocks Rethinking Diabetes

      January 1, 2026
      Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
      Biotech

      Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

      December 31, 2025
      « 1 … 5 6 7 8 9 … 134 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026